Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Akers Biosciences Inc. (AKER)

3.11   -0.07 (-2.2%) 02-14 16:00
Open: 3.18 Pre. Close: 3.18
High: 3.2507 Low: 3.08
Volume: 112,569 Market Cap: 5M
Akers Biosciences Inc is engaged in the development and sale of disposable diagnostic testing device. The Company develops, manufactures, and supplies rapid, point-of-care screening and testing products.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.258 - 3.274 3.274 - 3.287
Low: 3.037 - 3.058 3.058 - 3.075
Close: 3.08 - 3.112 3.112 - 3.138

Technical analysis

as of: 2020-02-14 4:26:27 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.21     One year: 4.79
Support: Support1: 2.80    Support2: 2.33
Resistance: Resistance1: 3.60    Resistance2: 4.10
Pivot: 3.13
Moving Average: MA(5): 3.15     MA(20): 3.20
MA(100): 6.09     MA(250): 11.96
MACD: MACD(12,26): -0.12     Signal(9): -0.16
Stochastic oscillator: %K(14,3): 26.41     %D(3): 27.44
RSI: RSI(14): 42.92
52-week: High: 30.24  Low: 2.67  Change(%): -85.4
Average Vol(K): 3-Month: 18616  10-Days: 22784

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
AKER has closed above bottom band by 47.1%. Bollinger Bands are 62.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to AKER's normal range. The bands have been in this narrow range for 34 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2020-02-06
Equinor: Floating Wind Farms a Natural Fit for Oil and Gas Companies
The cost of floating wind farms is on a steeper decline than traditional offshore wind, making the emerging sector increasingly attractive to oil and gas companies, said Sebastian Bringsværd, head of floating wind development at Norwegian energy giant Equinor. After years of industry anticipation without a lot to show for it, the floating wind market is finally gaining momentum in a commercially meaningful way. The goal, Bringsværd said, is to scale floating projects up to a comparable level as traditional projects, which are often 500 megawatts or larger, taking advantage of offshore wind’s huge economies of scale. Just a few years ago that was an “ambitious” vision,” Bringsværd said. “Now I see that's very realistic.” Equinor, among Europe’s largest oil producers, carved out an early leadership position in the emerging floating wind sector, completing the industry’s first full-scale project several years ago, the 30-megawatt Hywind Scotland. ACS’ 50-megawatt Kincardine Bay floating project, also off the coast of Scotland, will go into operation later this year, setting a new industry benchmark.

2019-12-06
The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 5) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD )(presented positive Phase 3 data for pimavanserin in dementia-related psychosis) Allergan plc (NYSE: AGN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Applied Therapeutics Inc (NASDAQ: APLT ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH )( reported positive readout for a pivotal trial in volcosporin for lupus nephritis) Bristol-Myers Squibb Co (NYSE: BMY ) Cassava Sciences Inc (NASDAQ: SAVA ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Flexion Therapeutics Inc (NASDAQ: FLXN ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Incyte Corporation (NASDAQ: INCY ) Merck & Co., Inc. (NYSE: MRK ) Morphosys Ag (NASDAQ: MOR ) NuVasive, Inc. (NASDAQ: NUVA ) Oyster Point Pharma Inc (NASDAQ: OYST ) PTC Therapeutics, Inc.

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Medical Instruments Supplies
Shares Out. (M) 1.74
Shares Float (M) 0.24
% Held by Insiders 6.72
% Held by Institutions 23.41
Shares Short (K) 24
Shares Short P. Month (K)

Stock Financials

EPS -12.518
Book Value (p.s.) 6.900
PEG Ratio
Profit Margin
Operating Margin -310.92
Return on Assets (ttm) -46.1
Return on Equity (ttm) -112.9
Qtrly Rev. Growth -24.5
Gross Profit (p.s.) 0.073
Sales Per Share
EBITDA (p.s.) -3.109
Qtrly Earnings Growth
Operating Cash Flow (M) -5.23
Levered Free Cash Flow (M) -3.40

Stock Valuations

P/E -0.25
P/E Growth Ratio -0.02
P/BV 0.45
P/S 0.89
P/CF -1.03

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-11-24
Last Split Ratio 0.042
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.